Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 319


Massive Fetal Transfusion During an Emergency Ex Utero Intrapartum Treatment for a Congenital Infantile Fibrosarcoma: A Case Report.

Oster AS, Reina E, Fehr JJ, Moore RP, Cox TE, George P.

A A Pract. 2019 Jun 11. doi: 10.1213/XAA.0000000000001050. [Epub ahead of print]


Experimental and computational analyses reveal that environmental restrictions shape HIV-1 spread in 3D cultures.

Imle A, Kumberger P, Schnellbächer ND, Fehr J, Carrillo-Bustamante P, Ales J, Schmidt P, Ritter C, Godinez WJ, Müller B, Rohr K, Hamprecht FA, Schwarz US, Graw F, Fackler OT.

Nat Commun. 2019 May 13;10(1):2144. doi: 10.1038/s41467-019-09879-3.


Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategies.

Wandeler G, Mauron E, Atkinson A, Dufour JF, Kraus D, Reiss P, Peters L, Dabis F, Fehr J, Bernasconi E, van der Valk M, Smit C, Gjærde LK, Rockstroh J, Neau D, Bonnet F, Rauch A; Swiss HIV Cohort Study, Athena Observational Cohort Study, EuroSIDA, ANRS CO3 Aquitaine Cohort.

J Hepatol. 2019 Apr 6. pii: S0168-8278(19)30226-0. doi: 10.1016/j.jhep.2019.03.032. [Epub ahead of print]


In Response.

Clebone A, Strupp KM, Fehr J, Burian BK.

Anesth Analg. 2019 Mar 27. doi: 10.1213/ANE.0000000000004138. [Epub ahead of print] No abstract available.


Low Antituberculosis Drug Concentrations in HIV-Tuberculosis-Coinfected Adults with Low Body Weight: Is It Time To Update Dosing Guidelines?

Sekaggya-Wiltshire C, Chirehwa M, Musaazi J, von Braun A, Buzibye A, Muller D, Gutteck U, Motta I, Calcagno A, Fehr JS, Kambugu A, Castelnuovo B, Lamorde M, Denti P.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e02174-18. doi: 10.1128/AAC.02174-18. Print 2019 Jun.


Clusters of sexual behaviour in HIV-positive men who have sex with men reveal highly dissimilar time trends.

Salazar-Vizcaya L, Kusejko K, Schmidt AJ, Carrillo-Montoya G, Nicca D, Wandeler G, Braun DL, Fehr J, Darling KEA, Bernasconi E, Schmid P, Günthard HF, Kouyos RD, Rauch A.

Clin Infect Dis. 2019 Mar 15. pii: ciz208. doi: 10.1093/cid/ciz208. [Epub ahead of print]


The Influence of Pharmacogenetic Variants in HIV/Tuberculosis Coinfected Patients in Uganda in the SOUTH Study.

Calcagno A, Cusato J, Sekaggya-Wiltshire C, von Braun A, Motta I, Turyasingura G, Castelnuovo B, Fehr J, Di Perri G, Lamorde M.

Clin Pharmacol Ther. 2019 Feb 19. doi: 10.1002/cpt.1403. [Epub ahead of print]


Changing Trends in International Versus Domestic HCV Transmission in HIV-Positive Men Who Have Sex With Men: A Perspective for the Direct-Acting Antiviral Scale-Up Era.

Salazar-Vizcaya L, Kouyos RD, Metzner KJ, Caraballo Cortes K, Böni J, Shah C, Fehr J, Braun DL, Bernasconi E, Mbunkah HA, Hoffmann M, Labhardt N, Cavassini M, Rougemont M, Günthard HF, Keiser O, Rauch A; Swiss HIV Cohort Study .

J Infect Dis. 2019 Jun 5;220(1):91-99. doi: 10.1093/infdis/jiz069.


Virological Outcome of Patients With HIV Drug Resistance Attending an Urban Outpatient Clinic in Uganda: A Need for Structured Adherence Counseling and Third-Line Treatment Options.

Baumann A, Musaazi J, Kambugu A, Kälin M, Weissberg D, Ssemwanga D, Fehr J, Castelnuovo B, Sekaggya-Wiltshire C, von Braun A.

J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):481-487. doi: 10.1097/QAI.0000000000001943.


Use of repellents by travellers: A randomised, quantitative analysis of applied dosage and an evaluation of knowledge, Attitudes and Practices (KAP).

Hasler T, Fehr J, Held U, Schlagenhauf P.

Travel Med Infect Dis. 2019 Mar - Apr;28:27-33. doi: 10.1016/j.tmaid.2018.12.007. Epub 2018 Dec 19.


Development and Usability Testing of the Society for Pediatric Anesthesia Pedi Crisis Mobile Application.

Clebone A, Strupp KM, Whitney G, Anderson MR, Hottle J, Fehr J, Yaster M, Schleelein LE, Burian BK, Galvez JA, Lockman JL, Polaner D, Barnett NR, Keane MJ, Manikappa S, Gleich S, Greenberg RS, Vincent A, Oswald SL, Starks R, Licata S; Pedi Crisis Application Working Group.

Anesth Analg. 2018 Dec 11. doi: 10.1213/ANE.0000000000003935. [Epub ahead of print]


Area of exposure and treatment challenges of malaria in Eritrean migrants: a GeoSentinel analysis.

Schlagenhauf P, Grobusch MP, Hamer DH, Asgeirsson H, Jensenius M, Eperon G, Rothe C, Isenring E, Fehr J, Schwartz E, Bottieau E, Barnett ED, McCarthy A, Kelly P, Schade Larsen C, van Genderen P, Stauffer W, Libman M, Gautret P.

Malar J. 2018 Nov 29;17(1):443. doi: 10.1186/s12936-018-2586-9.


Clinical Practice Guideline: Maintenance Intravenous Fluids in Children.

Feld LG, Neuspiel DR, Foster BA, Leu MG, Garber MD, Austin K, Basu RK, Conway EE Jr, Fehr JJ, Hawkins C, Kaplan RL, Rowe EV, Waseem M, Moritz ML; SUBCOMMITTEE ON FLUID AND ELECTROLYTE THERAPY.

Pediatrics. 2018 Dec;142(6). pii: e20183083. doi: 10.1542/peds.2018-3083. Review.


Importance of routine viral load monitoring: higher levels of resistance at ART failure in Uganda and Lesotho compared with Switzerland.

Bachmann N, von Braun A, Labhardt ND, Kadelka C, Günthard HF, Sekaggya-Wiltshire C, Castelnuovo B, Kambugu A, Lejone TI, Böni J, Yerly S, Perreau M, Klimkait T, Kouyos RD, Fehr J; Swiss HIV Cohort Study .

J Antimicrob Chemother. 2019 Feb 1;74(2):468-472. doi: 10.1093/jac/dky436.


Ten years of antiretroviral therapy: Incidences, patterns and risk factors of opportunistic infections in an urban Ugandan cohort.

Weissberg D, Mubiru F, Kambugu A, Fehr J, Kiragga A, von Braun A, Baumann A, Kaelin M, Sekaggya-Wiltshire C, Kamya M, Castelnuovo B.

PLoS One. 2018 Nov 1;13(11):e0206796. doi: 10.1371/journal.pone.0206796. eCollection 2018.


High purity high yield tandem B and T helper cell isolation for qRT-PCR analysis suitable for basically equipped laboratories.

Summerauer AM, Colombo L, Ogwang R, Berger C, Fehr J, Bürgler S.

Malar J. 2018 Oct 29;17(1):395. doi: 10.1186/s12936-018-2547-3.


High efavirenz serum concentrations in TB/HIV-coinfected Ugandan adults with a CYP2B6 516 TT genotype on anti-TB treatment.

von Braun A, Castelnuovo B, Ledergerber B, Cusato J, Buzibye A, Kambugu A, Fehr J, Calcagno A, Lamorde M, Sekaggya-Wiltshire C.

J Antimicrob Chemother. 2019 Jan 1;74(1):135-138. doi: 10.1093/jac/dky379.


High Number of Potential Transmitters Revealed in a Population-based Systematic Hepatitis C Virus RNA Screening Among Human Immunodeficiency Virus-infected Men Who Have Sex With Men.

Braun DL, Hampel B, Martin E, Kouyos R, Kusejko K, Grube C, Flepp M, Stöckle M, Conen A, Béguelin C, Schmid P, Delaloye J, Rougemont M, Bernasconi E, Rauch A, Günthard HF, Böni J, Fehr JS; Swiss HIV Cohort Study .

Clin Infect Dis. 2019 Feb 1;68(4):561-568. doi: 10.1093/cid/ciy545.


High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance Testing Among Human Immunodeficiency Virus/Hepatitis C Virus-coinfected Men Who Have Sex With Men.

Braun DL, Hampel B, Kouyos R, Nguyen H, Shah C, Flepp M, Stöckle M, Conen A, Béguelin C, Künzler-Heule P, Nicca D, Schmid P, Delaloye J, Rougemont M, Bernasconi E, Rauch A, Günthard HF, Böni J, Fehr JS; Swiss HIV Cohort Study .

Clin Infect Dis. 2019 Feb 1;68(4):569-576. doi: 10.1093/cid/ciy547.


Quantifying the drivers of HIV transmission and prevention in men who have sex with men: a population model-based analysis in Switzerland.

Kusejko K, Marzel A, Hampel B, Bachmann N, Nguyen H, Fehr J, Braun DL, Battegay M, Bernasconi E, Calmy A, Cavassini M, Hoffmann M, Böni J, Yerly S, Klimkait T, Perreau M, Rauch A, Günthard HF, Kouyos RD; Swiss HIV Cohort Study.

HIV Med. 2018 Nov;19(10):688-697. doi: 10.1111/hiv.12660. Epub 2018 Jul 26.


Impact of Direct-Acting Antivirals on the Burden of HCV Infection Among Persons Who Inject Drugs and Men Who Have Sex With Men in the Swiss HIV Cohort Study.

Salazar-Vizcaya L, Wandeler G, Fehr J, Braun D, Cavassini M, Stoeckle M, Bernasconi E, Hoffmann M, Rougemont M, Béguelin C, Rauch A; Swiss HIV Cohort Study .

Open Forum Infect Dis. 2018 Jun 26;5(7):ofy154. doi: 10.1093/ofid/ofy154. eCollection 2018 Jul.


Comparison of Löwenstein-Jensen and BACTEC MGIT 960 culture for Mycobacterium tuberculosis in people living with HIV.

Hongler J, Musaazi J, Ledergerber B, Eberhard N, Sekaggya-Wiltshire C, Keller PM, Fehr J, Castelnuovo B.

HIV Med. 2018 Oct;19(9):654-661. doi: 10.1111/hiv.12635. Epub 2018 Jul 3.


HIV pre-exposure prophylaxis (PrEP): Is it time to rethink HIV prevention in travelers?

Hampel B, Reinacher M, Fehr JS.

Travel Med Infect Dis. 2018 Sep - Oct;25:6-7. doi: 10.1016/j.tmaid.2018.06.008. Epub 2018 Jun 19. No abstract available.


HIV-1 Drug Resistance Among Ugandan Adults Attending an Urban Out-Patient Clinic.

von Braun A, Sekaggya-Wiltshire C, Bachmann N, Ssemwanga D, Scherrer AU, Nanyonjo M, Kapaata A, Kaleebu P, Günthard HF, Castelnuovo B, Fehr J, Kambugu A.

J Acquir Immune Defic Syndr. 2018 Aug 15;78(5):566-573. doi: 10.1097/QAI.0000000000001717.


Infectious disease profiles of Syrian and Eritrean migrants presenting in Europe: A systematic review.

Isenring E, Fehr J, Gültekin N, Schlagenhauf P.

Travel Med Infect Dis. 2018 Sep - Oct;25:65-76. doi: 10.1016/j.tmaid.2018.04.014. Epub 2018 Apr 24. Review.


Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin America.

Caro-Vega Y, Schultze A, W Efsen AM, Post FA, Panteleev A, Skrahin A, Miro JM, Girardi E, Podlekareva DN, Lundgren JD, Sierra-Madero J, Toibaro J, Andrade-Villanueva J, Tetradov S, Fehr J, Caylà J, Losso MH, Miller RF, Mocroft A, Kirk O, Crabtree-Ramírez B.

BMC Infect Dis. 2018 Apr 23;18(1):191. doi: 10.1186/s12879-018-3077-x.


Rapid decline of anti-hepatitis C virus (HCV) antibodies following early treatment of incident HCV infections in HIV-infected men who have sex with men.

Aebi-Popp K, Wandeler G, Salazar-Vizcaya L, Metzner K, Stöckle M, Cavassini M, Hoffmann M, Lüthi A, Suter F, Bernasconi E, Fehr J, Furrer H, Rauch A; the Swiss HIV Cohort Study.

HIV Med. 2018 Jul;19(6):420-425. doi: 10.1111/hiv.12602. Epub 2018 Mar 24.


Simulation and the diagnostic process: a pilot study of trauma and rapid response teams.

Juriga LL, Murray DJ, Boulet JR, Fehr JJ.

Diagnosis (Berl). 2017 Nov 27;4(4):241-249. doi: 10.1515/dx-2017-0010.


The utility of pharmacokinetic studies for the evaluation of exposure-response relationships for standard dose anti-tuberculosis drugs.

Sekaggya-Wiltshire C, Lamorde M, Kiragga AN, Dooley KE, Kamya MR, Kambugu A, Fehr J, Manabe YC, Castelnuovo B.

Tuberculosis (Edinb). 2018 Jan;108:77-82. doi: 10.1016/ Epub 2017 Nov 7. Review.


Delayed Sputum Culture Conversion in Tuberculosis-Human Immunodeficiency Virus-Coinfected Patients With Low Isoniazid and Rifampicin Concentrations.

Sekaggya-Wiltshire C, von Braun A, Lamorde M, Ledergerber B, Buzibye A, Henning L, Musaazi J, Gutteck U, Denti P, de Kock M, Jetter A, Byakika-Kibwika P, Eberhard N, Matovu J, Joloba M, Muller D, Manabe YC, Kamya MR, Corti N, Kambugu A, Castelnuovo B, Fehr JS.

Clin Infect Dis. 2018 Aug 16;67(5):708-716. doi: 10.1093/cid/ciy179.


Detection of tuberculosis patterns in digital photographs of chest X-ray images using Deep Learning: feasibility study.

Becker AS, Blüthgen C, Phi van VD, Sekaggya-Wiltshire C, Castelnuovo B, Kambugu A, Fehr J, Frauenfelder T.

Int J Tuberc Lung Dis. 2018 Mar 1;22(3):328-335. doi: 10.5588/ijtld.17.0520.


Correction to: Catheter retention as a consequence rather than a cause of unfavorable outcome in candidemia.

Damonti L, Erard V, Garbino J, Schrenzel J, Zimmerli S, Mühlethaler K, Imhof A, Zbinden R, Fehr J, Boggian K, Bruderer T, Flückiger U, Frei R, Orasch C, Conen A, Khanna N, Bregenzer T, Bille J, Lamoth F, Marchetti O, Bochud PY; Fungal Infection Network of Switzerland (FUNGINOS).

Intensive Care Med. 2018 Mar;44(3):405-407. doi: 10.1007/s00134-018-5081-4.


Fluconazole non-susceptible breakthrough candidemia after prolonged low-dose prophylaxis: a prospective FUNGINOS study.

Orasch C, Mertz D, Garbino J, van Delden C, Emonet S, Schrenzel J, Zimmerli S, Damonti L, Mühlethaler K, Imhof A, Ruef C, Fehr J, Zbinden R, Boggian K, Bruderer T, Flückiger U, Conen A, Khanna N, Frei R, Bregenzer T, Lamoth F, Erard V, Bochud PY, Calandra T, Bille J, Marchetti O; Fungal Infection Network of Switzerland (FUNGINOS).

J Infect. 2018 May;76(5):489-495. doi: 10.1016/j.jinf.2017.12.018. Epub 2018 Jan 31.


Excellent outcome of direct antiviral treatment for chronic hepatitis C in Switzerland.

Bachofner J, Valli PV, Bergamin I, Kröger A, Künzler P, Baserga A, Braun DL, Seifert B, Moncsek A, Fehr J, Semela D, Magenta L, Müllhaupt B, Terziroli Beretta-Piccoli B, Mertens J, The Swiss Hepatitis C Cohort Study.

Swiss Med Wkly. 2018 Jan 18;148:w14560. doi: 10.4414/smw.2018.14560. eCollection 2018.


Elevated Aspergillus-specific antibody levels among HIV infected Ugandans with pulmonary tuberculosis.

Kwizera R, Parkes-Ratanshi R, Page ID, Sekaggya-Wiltshire C, Musaazi J, Fehr J, Castelnuovo B, Kambugu A, Denning DW.

BMC Pulm Med. 2017 Nov 21;17(1):149. doi: 10.1186/s12890-017-0500-9.


Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030.

Bruggmann P, Blach S, Deltenre P, Fehr J, Kouyos R, Lavanchy D, Müllhaupt B, Rauch A, Razavi H, Schmid P, Semela D, Stoeckle M, Negro F.

Swiss Med Wkly. 2017 Nov 8;147:w14543. doi: 10.4414/smw.2017.14543. eCollection 2017.


Extraction Strings for Ureteric Stents: Is There an Increased Risk for Urinary Tract Infections?

Fröhlich M, Fehr J, Sulser T, Eberli D, Mortezavi A.

Surg Infect (Larchmt). 2017 Nov/Dec;18(8):936-940. doi: 10.1089/sur.2017.165. Epub 2017 Oct 4.


Cohort profile of a study on outcomes related to tuberculosis and antiretroviral drug concentrations in Uganda: design, methods and patient characteristics of the SOUTH study.

Sekaggya-Wiltshire C, Castelnuovo B, von Braun A, Musaazi J, Muller D, Buzibye A, Gutteck U, Henning L, Ledergerber B, Corti N, Lamorde M, Fehr J, Kambugu A.

BMJ Open. 2017 Sep 18;7(9):e014679. doi: 10.1136/bmjopen-2016-014679.


Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis.

Turk T, Bachmann N, Kadelka C, Böni J, Yerly S, Aubert V, Klimkait T, Battegay M, Bernasconi E, Calmy A, Cavassini M, Furrer H, Hoffmann M, Günthard HF, Kouyos RD; Swiss HIV Cohort Study, Aubert V, Battegay M, Bernasconi E, Böni J, Braun DL, Bucher HC, Calmy A, Cavassini M, Ciuffi A, Dollenmaier G, Egger M, Elzi L, Fehr J, Fellay J, Furrer H, Fux CA, Günthard HF, Haerry D, Hasse B, Hirsch HH, Hoffmann M, Hösli I, Kahlert C, Kaiser L, Keiser O, Klimkait T, Kouyos RD, Kovari H, Ledergerber B, Martinetti G, Martinez de Tejada B, Marzolini C, Metzner KJ, Müller N, Nicca D, Pantaleo G, Paioni P, Rauch A, Rudin C, Scherrer AU, Schmid P, Speck R, Stöckle M, Tarr P, Trkola A, Vernazza P, Wandeler G, Weber R, Yerly S.

Elife. 2017 Sep 12;6. pii: e28721. doi: 10.7554/eLife.28721.


Implementation and validation of the extended Hill-type muscle model with robust routing capabilities in LS-DYNA for active human body models.

Kleinbach C, Martynenko O, Promies J, Haeufle DFB, Fehr J, Schmitt S.

Biomed Eng Online. 2017 Sep 2;16(1):109. doi: 10.1186/s12938-017-0399-7.


Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study.

Béguelin C, Suter A, Bernasconi E, Fehr J, Kovari H, Bucher HC, Stoeckle M, Cavassini M, Rougemont M, Schmid P, Wandeler G, Rauch A; Swiss HIV Cohort Study.

Liver Int. 2018 Mar;38(3):424-431. doi: 10.1111/liv.13528. Epub 2017 Aug 23.


On the potential of a short-term intensive intervention to interrupt HCV transmission in HIV-positive men who have sex with men: A mathematical modelling study.

Salazar-Vizcaya L, Kouyos RD, Fehr J, Braun D, Estill J, Bernasconi E, Delaloye J, Stöckle M, Schmid P, Rougemont M, Wandeler G, Günthard HF, Keiser O, Rauch A; Swiss HIV Cohort Study.

J Viral Hepat. 2018 Jan;25(1):10-18. doi: 10.1111/jvh.12752. Epub 2017 Aug 23.


Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study.

Sculier D, Gayet-Ageron A, Battegay M, Cavassini M, Fehr J, Hirzel C, Schmid P, Bernasconi E, Calmy A; Swiss HIV Cohort Study.

BMC Infect Dis. 2017 Jul 6;17(1):476. doi: 10.1186/s12879-017-2579-2.


Assessing the need for a pre-exposure prophylaxis programme using the social media app Grindr®.

Hampel B, Kusejko K, Braun DL, Harrison-Quintana J, Kouyos R, Fehr J.

HIV Med. 2017 Nov;18(10):772-776. doi: 10.1111/hiv.12521. Epub 2017 May 19.


The Simulation-Based Assessment of Pediatric Rapid Response Teams.

Fehr JJ, McBride ME, Boulet JR, Murray DJ.

J Pediatr. 2017 Sep;188:258-262.e1. doi: 10.1016/j.jpeds.2017.03.030. Epub 2017 Apr 20.


Ocular Toxoplasmosis: Therapy-Related Adverse Drug Reactions and Their Management.

Helfenstein M, Zweifel S, Barthelmes D, Meier F, Fehr J, Böni C.

Klin Monbl Augenheilkd. 2017 Apr;234(4):556-560. doi: 10.1055/s-0042-123717. Epub 2017 Mar 22.


Catheter retention as a consequence rather than a cause of unfavorable outcome in candidemia.

Damonti L, Erard V, Garbino J, Schrenzel J, Zimmerli S, Mühlethaler K, Imhof A, Zbinden R, Fehr J, Boggian K, Bruderer T, Flückiger U, Frei R, Orasch C, Conen A, Khanna N, Bregenzer T, Bille J, Lamoth F, Marchetti O, Bochud PY; Fungal Infection Network of Switzerland (FUNGINOS).

Intensive Care Med. 2017 Jun;43(6):935-939. doi: 10.1007/s00134-017-4737-9. Epub 2017 Mar 7. No abstract available. Erratum in: Intensive Care Med. 2018 Feb 20;:.


Ethnicity predicts viral rebound after travel to the tropics in HIV-infected travelers to the tropics in the Swiss HIV Cohort Study.

Gebreselassie HM, Kraus D, Fux CA, Haubitz S, Scherrer A, Hatz C, Veit O, Stoeckle M, Fehr J, de Lucia S, Cavassini M, Bernasconi E, Schmid P, Furrer H, Staehelin C; Swiss HIV Cohort Study (SHCS).

HIV Med. 2017 Sep;18(8):564-572. doi: 10.1111/hiv.12491. Epub 2017 Mar 1.


Supplemental Content

Support Center